Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
12/30/2009 | EP2138485A1 Substituted N-Oxide pyrazine derivatives |
12/30/2009 | EP2137178A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
12/30/2009 | CA2728680A1 Substituted n-oxide pyrazine derivatives |
12/30/2009 | CA2728161A1 Therapeutic agent for inflammatory bowel disease |
12/30/2009 | CA2728089A1 Therapeutic agent for spinal canal stenosis |
12/29/2009 | US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors |
12/29/2009 | US7638627 Imatinib hydrochloride; reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidineamine with 4-(4-methyl-piperazinomethyl)benzoyl chloride; improved reduction step to simplify, increase yield, improve purity |
12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
12/29/2009 | US7638512 Phenylaminopropanol derivatives and methods of their use |
12/29/2009 | CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
12/24/2009 | US20090318697 Process for preparing a piperazine derivative |
12/24/2009 | US20090318696 Synthesis and use of MSE-framework type molecular sieves |
12/24/2009 | US20090318684 Rock inhibitors and uses thereof |
12/24/2009 | US20090318473 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
12/24/2009 | US20090318472 Aminopyrazine derivatives and compositions |
12/24/2009 | US20090318461 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid |
12/24/2009 | US20090318455 Compounds and methods for treating inflammatory and fibrotic disorders |
12/24/2009 | US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
12/24/2009 | US20090318389 Agonists of the sphingosine-1 phosphate receptor |
12/24/2009 | US20090315022 Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device |
12/23/2009 | WO2009154246A1 Therapeutic agent for erectile dysfunction |
12/23/2009 | WO2009152909A1 Quinoxalinedione derivatives |
12/23/2009 | EP2135863A1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
12/23/2009 | EP2134687A1 Piperazine and piperidine mglur5 potentiators |
12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
12/23/2009 | CN101610772A Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
12/23/2009 | CA2728018A1 Quinoxalinedione derivatives |
12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
12/22/2009 | US7635698 Compounds useful as chemokine receptor antagonists |
12/22/2009 | US7635697 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents |
12/22/2009 | CA2305803C Crystalline antifungal polymorph |
12/17/2009 | WO2009150109A1 Imidazolidine derivatives |
12/17/2009 | US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof |
12/17/2009 | US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists |
12/17/2009 | US20090312328 Sulfonamide compound or salt thereof |
12/17/2009 | US20090312315 Pai-1 inhibitor |
12/17/2009 | CA2725654A1 Imidazolidine derivatives |
12/16/2009 | CN101605767A Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
12/16/2009 | CN101602737A Benzenesulfonyl quinoxaline compound and preparation method and application thereof |
12/16/2009 | CN101602736A Synthesis method of quizalofop-p-ethyl |
12/16/2009 | CN101602735A Preparation method of ligustrazine |
12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
12/15/2009 | US7632838 11-beta HSD1 inhibitors |
12/15/2009 | US7632485 Catalytic radiofluorination |
12/15/2009 | CA2374580C Oligomers and polymers of cyclic imino carboxylic acids |
12/10/2009 | WO2009111623A3 Amorphous varenicline tartrate |
12/10/2009 | WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity |
12/10/2009 | US20090306382 Cationic alkoxyamines |
12/10/2009 | US20090306092 Method for treating cognitive deficits |
12/10/2009 | US20090306085 Hcv protease inhibitors and uses thereof |
12/09/2009 | EP2129653A2 Novel p2y12 receptor antagonists |
12/09/2009 | EP1994012B1 Novel tricyclic dihydropyrazines as potassium channel openers |
12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
12/09/2009 | EP1182183B1 Anthracene derivatives and organic electroluminescent devices made by using the same |
12/09/2009 | CN101597266A Synthesis of nickel-ion artificial antigen chelant and preparation of nickel monoclonal antibody |
12/09/2009 | CN100567268C Process for synthesis of amine ethers from secondary amino oxides |
12/08/2009 | US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament |
12/08/2009 | US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors |
12/08/2009 | US7629341 Human ADAM-10 inhibitors |
12/08/2009 | CA2374898C Pyrazinyl-piperazine compounds, their use and preparation |
12/08/2009 | CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
12/03/2009 | WO2009145591A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
12/03/2009 | WO2009145590A2 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof |
12/03/2009 | WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
12/03/2009 | WO2009145219A1 Therapeutic agent for alzheimer's disease |
12/03/2009 | WO2009108657A3 Heteroaryl derivatives as cftr modulators |
12/03/2009 | WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
12/03/2009 | WO2008139235A8 Novel piperazine salts as d3/d2 antagonists |
12/03/2009 | US20090299067 New synthesis of 2,6-diamino-3,5-dinitropyrazine-1-oxide from 2,6-diaminopyrazine-1-oxide |
12/03/2009 | US20090299064 Methods and intermediates for the preparation of optionally radio-labeled imatinib |
12/03/2009 | US20090299063 Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor |
12/03/2009 | US20090298853 Carbamoyl Compounds as DGAT1 Inhibitors 190 |
12/03/2009 | US20090298851 Phenyl piperazine compounds, pharmaceutical composition comprising the same and use thereof |
12/03/2009 | US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity |
12/03/2009 | US20090298842 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor |
12/03/2009 | US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof |
12/03/2009 | US20090298819 Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic Agents |
12/03/2009 | US20090297414 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
12/03/2009 | CA2729812A1 Therapeutic agent for alzheimer's disease |
12/03/2009 | CA2725563A1 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
12/03/2009 | CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
12/02/2009 | EP2125756A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
12/02/2009 | EP1515950B1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
12/02/2009 | EP1490346B1 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
12/02/2009 | EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents |
12/02/2009 | CN100564364C Method for integrally extracting and purifying ligustrazine, ferulic acid and volatile oil in ligusticum wallichii |
12/02/2009 | CN100564363C Method for refining dexrazoxane |
12/02/2009 | CN100564341C A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
12/01/2009 | US7626042 O-substituted hydroxyaryl derivatives |
12/01/2009 | US7626024 Processes and intermediates for the preparations of prostaglandins |
12/01/2009 | US7626023 Compounds for treating tumors |
12/01/2009 | US7626022 Method for producing β-heteroaryl-α-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds |
12/01/2009 | US7626019 Antiproliferative agents |
12/01/2009 | US7625938 Substituted pyrazoles, compositions containing such compounds and methods of use |
12/01/2009 | US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein |
12/01/2009 | US7625904 Methods for the treatment of sleep disorders |
12/01/2009 | US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor |